In conclusion, we comprehensively surveyed the expression, abundance, and membrane tumor localization of CD73 in early stage LUAD, and found that this immune marker with distinct clinicopathological, molecular, and immune characteristics. The gene discussed is NT5E; the disease is neoplasm.